financetom
Business
financetom
/
Business
/
Berger Paints Q4FY21: Saw highest industry growth in Q4; demand postponed, not gone away, says CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Berger Paints Q4FY21: Saw highest industry growth in Q4; demand postponed, not gone away, says CEO
May 27, 2021 5:12 AM

Berger Paints reported better than expected earnings for the fourth quarter of fiscal 2021 with a high net profit and revenue growth. Domestic volumes grew 60 percent and on the quarter-on-quarter (QoQ) basis, margin compression has been much lower than expected.

It reported the highest growth in the industry in Q4FY21 with strong performance seen in the waterproofing and construction chemicals, said Abhijit Roy, MD and CEO, Berger Paints.

Speaking to CNBC-TV18, Roy said that the month of April was good, but the company saw the lockdown impact in May.

However, he believes that the demand in the paint industry is postponed and hasn’t gone away.

“In paint, the demand doesn’t go away, it typically gets postponed. Whether it will come back in June or later on, we don’t know, sometimes it gets postponed but I am hopeful that we will again see better growth rates in the later months once the economy reopens,” he said.

Roy expects that it would not be easy to maintain margin at current levels as the old inventory raw material advantage has gone.

For the full interview, watch the accompanying video

(Edited by : Ankit Gohel)

First Published:May 27, 2021 2:12 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Albemarle Unusual Options Activity
Albemarle Unusual Options Activity
Mar 7, 2024
Investors with a lot of money to spend have taken a bullish stance on Albemarle . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ALB,...
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Mar 7, 2024
Thursday, Alligator Bioscience AB and Aptevo Therapeutics Inc ( APVO ) released interim data from the dose escalation phase of their Phase 1 trial evaluating ALG.APV-527 for solid tumors likely to express the tumor antigen 5T4. The multi-center, dose-escalation trial is now more than 50% enrolled, and preliminary results include: Treatment was overall well-tolerated, and a maximum tolerated dose has not yet been determined. Dose...
CompoSecure Shares Rise After Q4 Results Top Estimates
CompoSecure Shares Rise After Q4 Results Top Estimates
Mar 7, 2024
01:44 PM EST, 03/07/2024 (MT Newswires) -- CompoSecure ( CMPO ) shares jumped 30% in recent Thursday trading, a day after the company reported Q4 earnings and revenue that topped estimates by analysts. The company on Wednesday reported Q4 adjusted diluted earnings of $0.26 a share, up from $0.20 a year earlier. Analysts polled by Capital IQ expected $0.23. Revenue...
EV maker Rivian unveils smaller, less expensive SUVs, crossovers
EV maker Rivian unveils smaller, less expensive SUVs, crossovers
Mar 7, 2024
LAGUNA BEACH, California (Reuters) -Rivian on Thursday unveiled its smaller and less expensive R2 SUVs and R3 crossovers amid a slowdown in demand for EVs and also said it would start producing the R2 at its existing facility in Illinois to ensure deliveries in 2026. Rivian shares were up 10% at $12.16 on Thursday afternoon. The R2, with a starting...
Copyright 2023-2026 - www.financetom.com All Rights Reserved